Clinical Trial Update: To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing the oral bioavailability of empagliflozin + linagliptin 10 mg/5 mg fixed-dose tablets versus Glyxambi 10 mg/5 mg in heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (Jardiance) (empagliflozin)
• Linagliptin (Tradjenta) (linagliptin)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED